The enhanced control of hypertension and thrombolysis stroke study did not demonstrate the non-inferior effect of low-dose r-tPA to the standard-dose but indicated fewer symptomatic intracranial hemorrhage (sICH) with low-dose r-tPA (11). The gene discussed is PLAT; the disease is Hypertension.